Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) Gross Margin (2024 - 2025)

Upstream Bio has reported Gross Margin over the past 2 years, most recently at 1148.8% for Q4 2025.

  • Quarterly results put Gross Margin at 1148.8% for Q4 2025, down 79856.0% from a year ago — trailing twelve months through Dec 2025 was 706.34% (down 52339.0% YoY), and the annual figure for FY2025 was 706.34%, down 52870.0%.
  • Gross Margin for Q4 2025 was 1148.8% at Upstream Bio, down from 272.18% in the prior quarter.
  • Over the last five years, Gross Margin for UPB hit a ceiling of 45.16% in Q1 2024 and a floor of 1148.8% in Q4 2025.